With your consent we’ll provide this information to your organization’s account administrator to aid in the renewal decision and we will send you important updates about AdisInsight.
Please refer to our
privacy policy
for information on how we protect your personal information.
Verification link has been sent to the e-mail address entered below. Click on that link to proceed.
Do you need help? Please contact one of our AdisInsight experts. We aim to get back to you with personalized answer within 24 hours.
Our team would reach out to you shortly in response for your query.
The AskAdis AI conversational interface, unlocks the potential of AdisInsight data making it more accessible and versatile than ever. The power of AI combined with the breadth and depth of AdisInsight content means your conversational search can go beyond regular search facets to unearth additional facts and insights. It’s aim is to revolutionize the way information research is conducted in AdisInsight, the trusted drug information source in the format you need.
Try AskAdis AI now!Access to the AskAdis AI requires a subscription to AdisInsight.
Thank you for participating in the beta version of AskAdis AI. We appreciate your support and enthusiasm as we continue to enhance and improve the user experience. We highly encourage you to provide feedback, suggestions, and report any issues you encounter during your beta testing experience through the feedback link available on the AskAdis AI app page or the "Feedback" button on the left side on this page.
AskAdis AI allows access to AdisInsight data where you can type your queries in a chat field and answers are retrieved via an AI-driven natural language interface.
We recently added a timeline chart on all drug profiles. You can choose the indication from the drop down menu near the top. The chart will show the time the drug spent in different phases as it progressed through development for that indication. The end result is a Gantt style chart illustrating how long the drug took in each phase. This new chart takes advantage of our longitudinal pipeline data which we have stored every month since 2004. Please use the thumbs up/down buttons to let us know your opinion about this new feature.